Intrauterine contraceptive (progestogen) and breast cancer risk
A Danish study (78,595 new users; 78,595 non-users) found link between levonorgestrel-releasing intrauterine systems (LNG-IUSs) and increased breast cancer risk in females aged 15-49 years, vs non-use (hazard ratio 1.4; 95% confidence interval, 1.2-1.5) (1)
- the absolute risk low but there was excess risk of 14/10 000
- the risk did not increase with duration of use
The Danish study evidence contrasts with the results from a systematic review and meta-analysis by Heting et al (2):
- results suggested that LNG-IUS was not a risk factor for breast cancer
- the study authors note though that:
- since there were six articles that were not included in the meta-analysis and their data were not used, we should be cautious about this conclusion
Reference:
- Mørch LS, Meaidi A, Corn G, Hargreave M, Wessel Skovlund C. Breast Cancer in Users of Levonorgestrel-Releasing Intrauterine Systems. JAMA. Published online October 16, 2024.
- Heting M et al. Levonorgestrel intrauterine system and breast cancer risk: An updated systematic review and meta-analysis of observational studies. Heliyon. 2023 Mar 22;9(4):e14733.
Create an account to add page annotations
Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.